OptimizeRx Corp (OPRX) insider trading
Every open-market stock purchase and sale by OptimizeRx Corp executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $18.8K over the last 12 months (1 sale). No open-market buys.
- Last insider buy: James Paul Lang (Director), $2.4M, 19 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $18.8K (1 sale). Last close $9.37 on Oct 21, 2026.
Recent OPRX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 1, 2026 | Andrew J. D'Silva (C-suite exec) | Sold (not open market) | $3.5K |
| Sep 1, 2026 | Andrew J. D'Silva (C-suite exec) | Sold (not open market) | $11.3K |
| Aug 21, 2026 | Stephen L Silvestro (CEO) | Sold (not open market) | $13.4K |
| Aug 21, 2026 | Marion Odence-Ford (Officer) | Sold (not open market) | $11.8K |
| Aug 21, 2026 | Edward Stelmakh (Officer) | Sold (not open market) | $10.6K |
| Aug 21, 2026 | Andrew J. D'Silva (C-suite exec) | Sold (not open market) | $9.6K |
| Aug 21, 2026 | Brendan W. Merrell (COO) | Sold (not open market) | $7.9K |
| Aug 20, 2026 | Marion Odence-Ford (Officer) | Bought (not open market) | — |
| Aug 20, 2026 | Stephen L Silvestro (CEO) | Bought (not open market) | — |
| Aug 20, 2026 | Andrew J. D'Silva (C-suite exec) | Bought (not open market) | — |
| Aug 20, 2026 | Brendan W. Merrell (COO) | Bought (not open market) | — |
| Jun 9, 2026 | Ellen O'Connor Vos (Director) | Bought (not open market) | — |
| Jun 9, 2026 | Cathy Klema (Director) | Bought (not open market) | — |
| Jun 9, 2026 | James Paul Lang (Director) | Bought (not open market) | — |
| Jun 9, 2026 | Mariyamma Varghese Presti (Director) | Bought (not open market) | — |
| Jun 9, 2026 | Patrick D Spangler (Director) | Bought (not open market) | — |
| Jun 9, 2026 | Gregory D Wasson (Director) | Bought (not open market) | — |
| May 15, 2026 | Stephen L Silvestro (CEO) | Sold (not open market) | $27.2K |
| May 15, 2026 | Theresa Greco (C-suite exec) | Sold (not open market) | $4.8K |
| May 15, 2026 | Theresa Greco (C-suite exec) | Sold (not open market) | $4.6K |
| May 1, 2026 | Mariyamma Varghese Presti (Director) | Bought (not open market) | — |
| Feb 11, 2026 | Marion Odence-Ford (Officer) | Sold (not open market) | $12.8K |
| Feb 11, 2026 | Marion Odence-Ford (Officer) | Bought (not open market) | — |
| Dec 23, 2025 | Doug Besch (Officer) | Sold (not open market) | $52K |
| Dec 23, 2025 | Marion Odence-Ford (Officer) | Sold (not open market) | $51.6K |
Who's trading OPRX
- Andrew J. D'Silva, C-suite exec: other filings, last Oct 1, 2026
- Edward Stelmakh, CFO: sold $18.8K (1 sale), last Aug 21, 2026
- Brendan W. Merrell, COO: other filings, last Aug 21, 2026
- Stephen L Silvestro, C-suite exec: other filings, last Aug 21, 2026
- Marion Odence-Ford, C-suite exec: other filings, last Aug 21, 2026
- Gregory D Wasson, Director: other filings, last Jun 9, 2026
- Cathy Klema, Director: other filings, last Jun 9, 2026
- James Paul Lang, Director: other filings, last Jun 9, 2026
- Mariyamma Varghese Presti, Director: other filings, last Jun 9, 2026
- Patrick D Spangler, Director: other filings, last Jun 9, 2026
- Ellen O'Connor Vos, Director: other filings, last Jun 9, 2026
- Theresa Greco, C-suite exec: other filings, last May 15, 2026
- Doug Besch, C-suite exec: other filings, last Dec 23, 2025
Get free alerts when an insider at OptimizeRx Corp files a new trade →